NEVIS

1 NS SLT DEVICE ON THE MARKET
Selective Laser Trabeculoplasty (SLT) is an advanced, non-invasive, primary or secondary treatment for raised intraocular pressure (IOP) in glaucoma.
It uses short laser pulses of a specific wavelength to selectively target pigmented trabecular meshwork cells  Standard SLT utilises a low-energy laser with a short pulse duration of 3-5 ns. This low-energy irradiation stimulates removal of damaged cells by macrophages and increases trabecular network porosity to restore effective aqueous outflow through the drainage angle. This results in the reduction of IOP to non-pathologic levels.

DIODE PUMPED SOLID STATE LASER DEVICE ON THE MARKET FOR SLT
The OptoSLT nano is a new laser technology on the market. It offers very high pulse to pulse stability (±2.5%).
By reducing laser pulse duration to 1 ns without compromising efficacy outcomes, this new technology permits faster (up to 5 Hz) and safer SLT procedures (improved pulse energy repeatability during SLT).
With a compact, portable design, the OptoSLT nano is a good addition to every doctor’s practice. The device’s energy levels range from 0.2 to 2.0mJ and its red diode 635 nm aiming beam ensures precise focusing for highly predictive and effective treatment each and every time.
The OptoSLT nano offers a laser pulse duration of just 1 ns, with advanced technology in the form of a stable and efficient solid-state diode–pumped laser technology, thus offering a quick and safe SLT treatment option.

DIODE PUMPED SOLID STATE LASER SOURCE - DPSS
FOR MAXIMUM EFFICIENCY AND SAFETY
The compact and miniaturized solid state laser used in the OptoSLTnano offers additional safety and reliability benefits.

PPS™ - Pulse to Pulse Stability

Better energy stability and faster SLT treatment
The new device utilizes PPS technology to achieve a very high pulse to pulse stability of ±2.5%. This technology permits faster SLT procedures (up to 5 Hz) that are even safer on the market (due to improved pulse energy repeatability SLT treatment.)